New York, February 06, 2013 -- Moody's Investors Service assigned a Ba3 rating to American Renal Holdings, Inc.'s ("American Renal") proposed $450 million senior secured credit facilities, consisting of a $50 million revolver expiring 2018 and a $400 million term loan B due 2019. In addition, Moody's assigned a Caa1 rating to the proposed $240 million senior secured second lien term loan due 2020. American Renal's B2 Corporate Family Rating and B2-PD Probability of Default Rating are affirmed. The outlook is stable.

Vollständigen Artikel bei Moodys lesen